STOCK TITAN

Verano Announces Conference Participation for December

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced executive participation in upcoming conferences: Wolfe Consumer Growth Conference on December 5, Cowen’s 5th Annual Cannabis Conference on December 6, and Stifel Canada’s 3rd Annual Future of Healthcare Conference on December 7. CEO George Archos and CIO Aaron Miles will feature in discussions, highlighting Verano's commitment to cannabis wellness. The company operates in 14 states with over 1 million square feet of cultivation capacity, offering a range of trusted cannabis brands.

Positive
  • Executive participation in multiple industry conferences enhances visibility.
  • Strong operational presence in 14 U.S. states, indicating robust market engagement.
  • Over 1 million square feet of cultivation capacity supports product availability.
Negative
  • None.

CHICAGO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that members of its executive leadership team will participate in the following conferences:

Wolfe Consumer Growth Conference
Aaron Miles, Chief Investment Officer, will participate in a panel.
DATE: December 5, 2022
TIME: 2:20 p.m. CT

Cowen’s 5th Annual Cannabis Conference
George Archos, Founder & Chief Executive Officer, will participate in a fireside chat.
DATE: December 6, 2022
TIME: 11:10 a.m. CT
LINK: https://wsw.com/webcast/cowen125/vrnof/2207964

Stifel Canada’s 3rd Annual Future of Healthcare Conference
George Archos, Founder & Chief Executive Officer, will participate in a panel.
DATE: December 7, 2022
TIME: 11:00 a.m. CT
LINK: https://wsw.com/webcast/stifel73/register.aspx?conf=stifel73&page=panel3&url=https://wsw.co m/webcast/stifel73/panel3/2333331

About Verano

Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano, Avexia™, BITS™, Encore, MŪV and Savvy. Verano’s portfolio encompasses 14 U.S. states, with active operations in 13, including 14 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf and MŪV, delivering a superior cannabis shopping experience in both medical and adult use markets. Learn more at www.verano.com.

Contacts:

Media
Verano
Steve Mazeika
Director, Communications
Steve.Mazeika@verano.com
312-348-4430

Investors
Verano
Julianna Paterra, CFA
Director, Investor Relations
investors@verano.com

Forward Looking Statements

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s registration statement on Form 10, as amended, and quarterly reports on Form 10-Q filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###


FAQ

What conferences is Verano Holdings participating in December 2022?

Verano Holdings is participating in the Wolfe Consumer Growth Conference on December 5, Cowen’s 5th Annual Cannabis Conference on December 6, and Stifel Canada’s 3rd Annual Future of Healthcare Conference on December 7.

Who from Verano is speaking at the Wolfe Consumer Growth Conference?

Aaron Miles, Chief Investment Officer, will participate in a panel at the Wolfe Consumer Growth Conference.

What is the focus of Verano's brand offerings?

Verano offers a comprehensive suite of premium cannabis products under brands like Verano, Avexia, and MŪV.

How many states does Verano operate in?

Verano operates in 14 U.S. states.

What is the significance of Verano's cultivation capacity?

Verano's cultivation capacity exceeds 1 million square feet, enabling significant production capabilities.

VERANO HLDGS CORP

OTC:VRNOF

VRNOF Rankings

VRNOF Latest News

VRNOF Stock Data

610.70M
302.30M
15.59%
10.6%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago